Numerion Labs
YC W15 ↗San Francisco, US · 67 employees · 4 known investors
Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
AI & Machine LearningBiotechHealthtechMedical DevicesAI-powered Drug DiscoveryDeep LearningDrug discoveryOncologyin /atomwise/@atomwiseincycombinator.com ↗
Founders & leadership· Y Combinator alumni (W15)
IW
Izhar WallachinFounder
SW
Steve WorlandCEO
PT
Pamela TsurudaVP, Biology
MS
Mark SabatVP, Medicinal Chemistry
KS
Kate StaffordVP, Machine Learning
RM
Robert Mittendorf
AS
Adam Seabrook
MV
Mike Varney
KM
Kemal Malik